Markets

Zimmer Holdings (ZMH) Tops Q1 Earnings, Revenues Miss the Mark - Tale of the Tape

Ever undergone reconstructive orthopedic surgery? Yes, then you may have been implanted with one of the personalized joint replacement technologies of Indiana-based, one of the leading orthopedic medical devices manufacturer - Zimmer Holdings, Inc . ( ZMH ). With operations in more than 25 countries, the company markets its orthopedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products in more than 100 countries.

Currently, Zimmer Holdings has a Zacks Rank #3 (Hold) but that could change following its first quarter 2015 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings : The current Zacks Consensus Estimate stands at $1.54 per share. Zimmer's adjusted earnings per share of $1.58 beat this estimate by 2.6%.

Revenues : Zimmer posted revenues of $1.13 billion, which missed the Zacks Consensus Estimate for revenues of $1.15 billion.

Key Stats : Revenues derived from Zimmer's Knees segment (within Reconstructive) were up 6% year over year at CER to $487.3 million, while Hips recorded sales of $312.2 million, up 3% compared with the prior-year quarter. Revenues from Extremities increased 5% year over year to $52.2 million.

Major Factors : In the first quarter, Zimmer achieved steady sales growth in several geographies and product categories, met the company's financial commitments and delivered expanded operating margin leverage. Notably, the company recently received approval from the European Commission and the Japan Fair Trade Commission for its pending combination with Biomet, which is now expected to close during the month of May, 2015.

Stock Price : Following the earnings release, share prices did not show any movement in the pre-market trading session.

Check back later for our full write up on this Zimmer Holdings earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ZIMMER HOLDINGS (ZMH): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.